FDA Staff Grapples With Absent Clinical Efficacy Data for Nasal Epinephrine

(MedPage Today) -- A lack of clinical efficacy data on epinephrine nasal spray remained a chief concern for FDA reviewers as the agency considers approval of the first noninjectable product for treating allergic reactions, including anaphylaxis...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news